Vertex Pharmaceuticals
VRTX
#140
Rank
NZ$196.86 B
Marketcap
$764.44
Share price
-0.59%
Change (1 day)
29.39%
Change (1 year)

Operating Margin for Vertex Pharmaceuticals (VRTX)

Operating Margin as of November 2024 (TTM): 44.37%

According to Vertex Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 44.37%. At the end of 2023 the company had an Operating Margin of 44.38%.

Operating Margin history for Vertex Pharmaceuticals from 2001 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
202344.38%-6.36%
202247.39%31.47%
202136.05%-28.23%
202050.23%49.89%
201933.51%70.13%
201819.70%-3224.19%
2017-0.63%-84.07%
2016-3.96%-92.68%
2015-54.03%-57.32%
2014-126.61%145.11%
2013-51.65%-2565.28%
20122.10%-51.1%
20114.28%-100.81%
2010-526.35%-16.49%
2009-630.27%141.32%
2008-261.18%25.96%
2007-207.36%99.05%
2006-104.17%18.25%
2005-88.10%-34.06%
2004-133.60%-46.51%
2003-249.78%59.99%
2002-156.12%15.7%
2001-134.94%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
5.53%-87.54%๐Ÿ‡บ๐Ÿ‡ธ USA
12.84%-71.06%๐Ÿ‡บ๐Ÿ‡ธ USA
3.14%-92.92%๐Ÿ‡บ๐Ÿ‡ธ USA
-14.50%-132.68%๐Ÿ‡บ๐Ÿ‡ธ USA
17.68%-60.15%๐Ÿ‡บ๐Ÿ‡ธ USA
-148.15%-433.90%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.